Our Goal: to provide an easy, affordable and informative means for our customers to purchase home medical equipment and supplies from the comfort of their homes and medical offices.
ThromboGenics acquires rights to eye treatment technology
BRUSSELS (Reuters) - Belgian biopharmaceutical company ThromboGenics said on Thursday it had entered into an agreement with British peer Bicycle Therapeutics to develop and launch new drugs to treat opthalmic diseases.
No comments:
Post a Comment